Home > Investor Relations

  • 3Q Results - Fiscal Year 2014 (Jan-Sep 2014)

  • Annual Report 2013 (Integrated Edition Including CSR Report)

  • Aiming to Become a Top Pharmaceutical Company with Global-Level Capabilities